Top

BMC Medical Imaging

Published in:

01-12-2020 | Magnetic Resonance Imaging | Research article

Comparison of BSGI, MRI, mammography, and ultrasound for the diagnosis of breast lesions and their correlations with specific molecular subtypes in Chinese women

Authors: Hongbiao Liu, Hongwei Zhan, Da Sun, Ying Zhang

Published in: BMC Medical Imaging | Issue 1/2020

Abstract

Background

Breast cancer is a leading cause of cancer in females, and is the second leading cancer-related cause of death in this group. Early diagnosis is essential to breast cancer to be effectively treated, and ultrasound, mammography, and magnetic resonance imaging (MRI) represent three key technologies that are utilized for the diagnosis of breast lesions. Breast-specific gamma imaging (BSGI) is an approach to molecular breast imaging that allows for high-resolution radio-imaging that is not adversely impacted by breast tissue density. This study was therefore designed to assess the relative diagnostic efficacy of BSGI, MRI, mammography, and ultrasound in different molecular subtypes of breast cancer among Chinese women.

Methods

Diagnostic findings from 390 patients that had undergone diagnosis and treatment in our breast surgery department were retrospectively reviewed. Patients had been diagnosed via BSGI, mammography, ultrasound, and MRI. The diagnostic efficacy of these different imaging modalities and their associated biological characteristics were compared in the present study.

Results

A total of 229 of these 390 patients (58.7%) were diagnosed with malignant breast cancer, with the remaining 161 (41.3%) cases having been found to be benign. BSGI, MRI, mammography, and ultrasound yielded respective sensitivity values of 91.7, 92.5, 77.3, and 82.1%, while the respective specificity values for these imaging modalities were 80.7, 69.7, 74.5, and 70.8%. For lesions > 1 cm, BSGI offered a sensitivity of 92.5%. For mammographic breast density A, B, C, and D, BSGI offered a sensitivity of 93.3, 94.0, 91.5, and 89.3%, respectively. BSGI also yielded a significantly higher lesion-to-normal lesion ratio (LNR) for malignant lesions relative to benign lesions (2.76 ± 1.32 vs 1.46 ± 0.49).

Conclusions

These findings confirm that BSGI is highly sensitive and is superior to mammography in the detection and diagnosis of ductal carcinomas in situ (DCIS). Such diagnostic efficacy can be further improved by using BSGI as an auxiliary modality to mammography and ultrasound, potentially improving the reliability of breast lesion diagnosis, thereby ensuring that patients receive rapid and effective treatment without the risk of misdiagnosis or unnecessary surgical treatment.

Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei R, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2018;4(11):1553–68. https://doi.org/10.1001/jamaoncol.2018.2706.CrossRef

Vellaisamy G, Tirumalae R, Inchara YK. Expression of androgen receptor in primary breast carcinoma and its relation with Clinicopathologic features, estrogen, progesterone, and her-2 receptor status. J Cancer Res Ther. 2019;15(5):989–93. https://doi.org/10.4103/jcrt.JCRT_572_17.CrossRefPubMed

Qi J-P, Yang Y-L, Zhu H, et al. Expression of the androgen receptor and its correlation with molecular subtypes in 980 Chinese breast Cancer patients. Breast Cancer (Auckl). 2012;6:1–8. https://doi.org/10.4137/BCBCR.S8323 Epub 2011 Dec 6.CrossRef

Goldsmith SJ, Parsons W, Guiberteau MJ, Stern LH, Lanzkowsky L, Weigert J, et al. SNM practice guideline for breast scintigraphy with breast-specific gamma-cameras 1.0. J Nucl Med Technol. 2010;38(4):219–24. https://doi.org/10.2967/jnmt.110.082271 Epub 2010 Nov 5.CrossRefPubMed

Liu H, Zhan H, Sun D. Comparison of 99mTc-MIBI scintigraphy, ultrasound, and mammography for the diagnosis of BI-RADS 4 category lesions. BMC Cancer. 2020 May 24;20(1):463. https://doi.org/10.1186/s12885-020-06938-7.CrossRefPubMedPubMedCentral

Rosenberg RD, Hunt WC, Williamson MR, Gilliland FD, Wiest PW, Kelsey CA, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis:review of 183, 134 screening mammograms in Albuquerque, New Mexico. Radiology. 1998;209(2):511–8. https://doi.org/10.1148/radiology.209.2.9807581.CrossRefPubMed

Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356(3):227–36. https://doi.org/10.1056/NEJMoa062790.CrossRefPubMed

Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA, et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer I. 2006;98(17):1204–14. https://doi.org/10.1093/jnci/djj331.CrossRef

Rechtman LR, Lenihan MJ, Lieberman JH, et al. Breast-specific gamma imaging for the detection of breast cancer in dense versus nondense breasts. AJR Am J Roentgenol. 2014;202(2):293–8. https://doi.org/10.2214/AJR.13.11585.CrossRefPubMed

10.

Chung HW, So Y, Yang JH, et al. Adjunctive breast-specific gamma imaging for detecting Cancer in women with calcifications at mammography. Ann Surg Oncol. 2017;24(12):3541–8. https://doi.org/10.1245/s10434-017-6058-1.CrossRefPubMed

11.

Tiwari P, Ghosh S, Agrawal VK. Evaluation of breast lesions by digital mammography and ultrasound along with fine-needle aspiration cytology correlation. J Cancer Res Ther. 2018;14(5):1071–4. https://doi.org/10.4103/0973-1482.191053.CrossRefPubMed

12.

Tadwalkar RV, Rapelyea JA, Torrente J, Rechtman LR, Teal CB, McSwain AP, et al. Breast-specific gamma imaging as all adjunct modality for the diagnosis of invasive breast cancer with correlation to tumor size and grade. Br J Radiol. 2012;85(1014):e212–6. https://doi.org/10.1259/bjr/34392802 Epub 2011 Jun 28.CrossRefPubMedPubMedCentral

13.

Spanu A, Sanna D, Chessa F, Manca A, Cottu P, Fancellu A, Nuvoli S, Madeddu G. The clinical impact of breast scintigraphy acquired with a breast specific γ-camera (BSGC) in the diagnosis of breast cancer: incremental value versus mammography. Int J Oncol. 2012;41(2):483–9. https://doi.org/10.3892/ijo.2012.1495 Epub 2012 May 24.CrossRefPubMed

14.

Sampalis FS, Denis R, Picard D, Fleiszer D, Martin G, Nassif E, et al. International prospective evaluation of scintimammography with 99m-technetium sestamibi. Am J Surg. 2003;185(6):544–9.CrossRef

15.

Kim SJ, Kim IJ, Bae YT, Kim YK, Kim DS. Comparison of quantitative and visual analysis of Tc-99m MIBI scintimammography for detection of primary breast cancer. Eur J Radiol. 2005;53(2):192–8. https://doi.org/10.1016/j.ejrad.2003.10.024.CrossRefPubMed

16.

Choi EK, Im JJ, Park CS, Chung YA, Kim K, Oh JK. Usefulness of feature analysis of breast-specific gamma imaging for predicting malignancy. Eur Radiol. 2018;28(12):5195–202. https://doi.org/10.1007/s00330-018-5563-3.CrossRefPubMed

17.

Sun Y, Wei W, Yang HW, Liu JL. Clinical usefulness of breast-specific gamma imaging as an adjunct modality to mammography for diagnosis of breast cancer: a systemic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2013;40(3):450–63. https://doi.org/10.1007/s00259-012-2279-5 Epub 2012 Nov 14.CrossRefPubMed

18.

Weigert JM, Bertrand ML, Lanzkowsky L, Stern LH, Kieper DA. Results of a multicenter patient registry to determine the clinical impact of breast-specific gamma imaging, a molecular breast imaging technique. AJR Am J Roentgenol. 2012 Jan;198(1):W69–75. https://doi.org/10.2214/AJR.10.6105.CrossRefPubMed

19.

Xing D, Lv Y, Sun B, et al. Diagnostic value of contrast-enhanced spectral mammography in comparison to magnetic resonance imaging in breast lesions. J Comput Assist Tomogr. 2019;43(2):245–51. https://doi.org/10.1097/RCT.0000000000000832.CrossRefPubMed

20.

Bilimoria KY, Cambic A, Hansen NM, Bethke KP. Evaluating the impact of pre-operativebreast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers. Arch Surg. 2007;142(5):441–5 discussion 445-7.CrossRef

21.

Hwang N, Schiller DE, Crystal P, Maki E, McCready DR. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy. Ann Surg Oncol. 2009;16(11):3000–9. https://doi.org/10.1245/s10434-009-0607-1.CrossRefPubMed

22.

Yoon JH, Jung HK, Lee JT, Ko KH. Shear-wave elastography in the diagnosis of solid breast masses: what leads to false-negative or false-positive results? Eur Radiol. 2013;23(9):2432–40. https://doi.org/10.1007/s00330-013-2854-6 Epub 2013 May 15.CrossRefPubMed

23.

Kim MY, Choi N, Yang JH, Yoo YB, Park KS. False positive or negative results of shear-wave elastography in differentiating benign from malignant breast masses: analysis of clinical and ultrasonographic characteristics. Acta Radiol. 2015;56(10):1155–62. https://doi.org/10.1177/0284185114551400.CrossRefPubMed

24.

Fallenberg EM, Schmitzberger FF, Amer H, Ingold-Heppner B, Balleyguier C, Diekmann F, et al. Contrast-enhanced spectral mammography vs. mammography and MRI-clinical performance in a multi-reader evaluation. Eur Radiol. 2017;27(7):2752–64. https://doi.org/10.1007/s00330-016-4650-6.CrossRefPubMed

25.

Jones EA, Phan TD, Blanchard DA, Miley A. Breast-specific gamma-imaging: molecular imaging of the breast using 99mTc-sestamibi and a small-field-of-view gamma-camera. J Nucl Med Technol. 2009;37(4):201–5. https://doi.org/10.2967/jnmt.109.063537 Epub 2009 Nov 13.CrossRefPubMed

26.

Park JS, Lee AY, Jung KP, Choi SJ, Lee SM, Kyun BS. Diagnostic performance of breast-specific gamma imaging (BSGI) for breast cancer: usefulness of dual-phase imaging with (99m)Tc-sestamibi. J Nucl Med Mol Imaging. 2013;47(1):18–26. https://doi.org/10.1007/s13139-012-0176-2 Epub 2012 Oct 13.CrossRef

27.

Rhodes DJ, Hruska CB, Conners AL, et al. Journal club: molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts. AJR Am J Roentgenol. 2015;204(2):241–51. https://doi.org/10.2214/AJR.14.13357.CrossRefPubMedPubMedCentral

Title: Comparison of BSGI, MRI, mammography, and ultrasound for the diagnosis of breast lesions and their correlations with specific molecular subtypes in Chinese women
Authors: Hongbiao Liu
Hongwei Zhan
Da Sun
Ying Zhang
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Magnetic Resonance Imaging
Ultrasound
Magnetic Resonance Imaging
Breast Cancer
Mammography
Breast Cancer
Ultrasound
Scintigraphy
Mammography
Published in: BMC Medical Imaging / Issue 1/2020
Electronic ISSN: 1471-2342
DOI: https://doi.org/10.1186/s12880-020-00497-w

At a glance: The STEP trials

Springer Medicine

Comparison of BSGI, MRI, mammography, and ultrasound for the diagnosis of breast lesions and their correlations with specific molecular subtypes in Chinese women

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2020

Localized biphasic malignant mesothelioma presenting as a giant pelvic wall mass: a rare case report and literature review

Utility of FDG PET/CT for assessment of lung nodules identified during low dose computed tomography screening

Diagnosis of foetal vein of galen aneurysmal malformation by ultrasound combined with magnetic resonance imaging: a case series

Differentiation between high-grade gliomas and solitary brain metastases: a comparison of five diffusion-weighted MRI models

The impact of 18F-FDOPA-PET/MRI image fusion in detecting liver metastasis in patients with neuroendocrine tumors of the gastrointestinal tract

Application of CareDose 4D combined with Karl 3D technology in the low dose computed tomography for the follow-up of COVID-19